43.8 F
New York
Sunday, January 29, 2023

Date:

Share:

Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology

Related Articles

Careington Proud to Sponsor 13th Annual Dr. Martin Luther King Jr. Essay and Oration Scholarship Competition

Frisco, TX, January 29, 2023 --(PR.com)-- Careington is proud to have served another year as a "Dream" level sponsor for the 13th annual Dr. Martin...

Dr. Patrick Hsu Named One of Texas Super Doctors 2022

Houston, TX, January 27, 2023 --(PR.com)-- Dr. Patrick Hsu of Memorial Plastic Surgery has been named one of the Texas Super Doctors by Super Doctors...

The Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers

Press Release


Dec 22, 2022 06:01 PST

While medical devices have seen incredible advancements over the last 100 years, ocular drug delivery systems have seen minimal progress; the standard eye dropper used today has gone largely unchanged in the last century. Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing a pipeline of late-stage microdose array print (MAP™) therapeutics, is developing one of the first microdosing systems that aims…

Read more…

Popular Articles